Abstract
Abstract
Fifteen years ago we discovered activity-dependent neuroprotective protein (ADNP), and showed that it is essential for brain formation/function. Our protein interaction studies identified ADNP as a member of the chromatin remodeling complex, SWI/SNF also associated with alternative splicing of tau and prediction of tauopathy. Recently, we have identified cytoplasmic ADNP interactions with the autophagy regulating microtubule-associated protein 1 light chain 3 (LC3) and with microtubule end-binding (EB) proteins. The ADNP-EB-binding SIP domain is shared with the ADNP snippet drug candidate, NAPVSIPQ termed NAP (davunetide). Thus, we identified a precise target for ADNP/NAP (davunetide) neuroprotection toward improved drug development.
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference110 articles.
1. ev Mechanisms of regulating tubulin synthesis in cultured mammalian cells;Ben;Cell,1979
2. Sporadic autism exomes reveal a highly interconnected protein network ofde novomutations;Roak;Nature,2012
3. Sexual dimorphism of activity - dependent neuroprotective protein in the mouse arcuate nucleus;Furman;Neurosci Lett,2005
4. Effects of davunetide on acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia;Jarskog;Neuropsychopharmacology,2013
5. neuronal microtubule - interacting agent reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer s disease;Matsuoka;Pharmacol Exp Ther,2008
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献